Biomed Realty Trust (NYSE: BMR) and VEREIT (NYSE:VER) are both financials companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations and risk.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Biomed Realty Trust and VEREIT, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biomed Realty Trust 0 0 0 0 N/A
VEREIT 1 2 4 0 2.43

VEREIT has a consensus price target of $10.00, suggesting a potential upside of 26.26%.

Valuation & Earnings

This table compares Biomed Realty Trust and VEREIT’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
Biomed Realty Trust N/A N/A N/A N/A N/A
VEREIT $1,454.82 5.30 -$195.86 ($0.11) -71.99

Biomed Realty Trust has higher revenue, but lower earnings than VEREIT.


This table compares Biomed Realty Trust and VEREIT’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Biomed Realty Trust 18.98% 3.73% 2.07%
VEREIT -2.72% -0.44% -0.25%

Institutional and Insider Ownership

85.8% of VEREIT shares are owned by institutional investors. 0.1% of VEREIT shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.


VEREIT pays an annual dividend of $0.55 per share and has a dividend yield of 6.9%. Biomed Realty Trust does not pay a dividend. VEREIT pays out -500.0% of its earnings in the form of a dividend. Biomed Realty Trust has increased its dividend for 7 consecutive years.


VEREIT beats Biomed Realty Trust on 6 of the 10 factors compared between the two stocks.

Biomed Realty Trust Company Profile

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company’s tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company’s properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.

VEREIT Company Profile

VEREIT, Inc. is a full-service real estate operating company. The Company operates through two business segments: real estate investment (REI) segment and investment management segment, Cole Capital. As of December 31, 2016, through its REI segment, the Company owned and managed a portfolio of 4,142 retail, restaurant, office and industrial real estate properties with an aggregate of 93.3 million square feet, which are located in 49 states, Puerto Rico and Canada. Through its Cole Capital segment, the Company is responsible for raising capital for and managing the affairs of certain non-listed real estate investment trusts (the Cole REITs) on a day-to-day basis, identifying and making acquisitions and investments on the Cole REITs’ behalf. The Cole Capital segment sponsors and manages direct investment real estate programs, which primarily include over four publicly registered, non-traded REITs.

Receive News & Ratings for Biomed Realty Trust Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomed Realty Trust Inc and related companies with's FREE daily email newsletter.